Search results for "Lymph"

showing 10 items of 4590 documents

Pulmonary haemangiolymphangioma – a new entity of pulmonary vascular tumours?

2008

Pathologymedicine.medical_specialtyPediatricsLung NeoplasmsHistologyMEDLINEAntigens CD34Lung pathologyPathology and Forensic MedicineHemangiomaAntibodies Monoclonal Murine-DerivedText miningAntigenBiomarkers TumormedicineHumansHemangioma CapillaryLungLymphangiomabiologybusiness.industryAntibodies MonoclonalGeneral Medicinemedicine.diseaseHemangioma CavernousFluorescent Antibody Technique DirectMonoclonalbiology.proteinAntibodybusinessHistopathology
researchProduct

Contact hypersensitivity to disodium hexachloroplatinate in mice.

1998

Complex platinum (Pt) compounds are known as occupational respiratory sensitizers whereas their role in skin exposure is unclear. In this study, both skin irritation and induction of contact hypersensitivity by halide Pt salts were characterized in mice. Repeated application of Na2[PtCl6] (5% in acetone) to both ears of naive BALB/c mice induced activation of the draining auricular lymph nodes. Flow cytometric analysis revealed a striking increase in the number of lymph node cells expressing proliferating cell nuclear antigen. In separate experiments, Na2[PtCl6] or acetone were applied only to the right ear of mice on 4-8 consecutive days and the animals were challenged on the left ear 6 da…

Pathologymedicine.medical_specialtyPharmacologyToxicologyDermatitis Contactchemistry.chemical_compoundMiceProliferating Cell Nuclear AntigenmedicineAnimalsHumansRespiratory systemAllergic contact dermatitisSensitizationSodium hexachloroplatinateMice Inbred BALB CChemistryLocal lymph node assayEarGeneral Medicinemedicine.diseasemedicine.anatomical_structureToxicityDermatitis IrritantFemaleImmunizationLymphLymph NodesCisplatinContact dermatitisToxicology letters
researchProduct

A morphometric tool applied to angiogenesis research based on vessel segmentation

2013

Given that angiogenesis and lymphangiogenesis are strongly related to prognosis in neoplastic and other pathologies, and that some existing methods for their study provide different results, we aim to construct a morphometric tool to allow complete and accurate quantification and measurement of different aspects of the shape and size of vascular vessels.

Pathologymedicine.medical_specialtyProceedingsHistologybusiness.industryAngiogenesisResearch basedmedicineVessel segmentationGeneral MedicinebusinessPathology and Forensic MedicineLymphangiogenesisDiagnostic Pathology
researchProduct

C-erbB-2-oncogene expression in breast carcinoma: Analysis by S1 nuclease protection assay and immunohistochemistry in relation to clinical parameters

1992

The c-erbB-2 mRNA was detected by the S1 nuclease protection assay and Northern blotting in breast cancer tissues. In contrast to the Northern blot analysis which has been used in all recent publications concerning c-erbB-2 expression on the level of RNA, the S1-nuclease protection assay has distinct advantages with respect to sensitivity, reproducibility, and handling of radioactive probes. We compared the expression of c-erbB-2 in 120 breast carcinomas which were operated in the years 1989-1990 on the level of the mRNA (S1 nuclease protection assay) and the protein (immunohistochemistry), respectively. In general, results obtained with both methods were in good agreement. Only minor diffe…

Pathologymedicine.medical_specialtyReceptor ErbB-2Breast NeoplasmsBiologyGene Expression Regulation EnzymologicImmunoenzyme TechniquesBreast cancerProto-Oncogene ProteinsGene expressionmedicineHumansRNA NeoplasmNorthern blotskin and connective tissue diseasesLymph nodeOncogeneSingle-Strand Specific DNA and RNA EndonucleasesObstetrics and GynecologyBlotting Northernmedicine.diseaseSurvival AnalysisGene Expression Regulation NeoplasticBlotmedicine.anatomical_structureOncologyCancer researchImmunohistochemistryFemaleBreast carcinomaGynecologic Oncology
researchProduct

Papillary cystoadenoma lymphomatosum (Warthin-like) of minor salivary glands

2009

Papillary cystadenoma lymphomatosum is a benign salivary gland tumor most frequently located in the parotid gland (Warthin?s tumor). Its presentation in other major, or in minor, salivary glands is rare. Clinically, it manifests as a slow growing tumor, fluctuant on palpation due to its cystic morphology. The treatment of choice is complete excision with wide tumor-free margins. We present a 73-year-old female patient with an asymptomatic tumor of 8 years evolution in the right posterior area of the hard palate. We performed surgical excision and a biopsy, which was reported as papillary cystadenoma lymphomatosum. During the post-operative examination carried out after 3 weeks, it was obser…

Pathologymedicine.medical_specialtySalivary Glands MinorPalpationAsymptomaticLesionParòtidesPapillary CystadenomaBiopsymedicineHumansGeneral DentistryAgedTumorsPeriosteummedicine.diagnostic_testbusiness.industryMalalties de les glàndules salivalsSalivary gland diseases:CIENCIAS MÉDICAS [UNESCO]AdenolymphomaSalivary Gland NeoplasmsParotid glandsParotid glandmedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryFemaleHard palatemedicine.symptombusiness
researchProduct

Immunohistochemical expression of Bcl-2 in benign and malignant salivary gland tumors

2010

Objectives: The present study was undertaken to assess and compare the immunohistochemical expression of Bcl-2 in selected benign and malignant salivary gland tumors. Study Design: A total of 50 cases of buffered formalin-fixed, paraffin embedded tissues of previously diagnosed cases of benign and malignant salivary gland tumors from the archives of Department of Oral and Maxillofacial Pathology and Microbiology, SDM College of Dental Sciences and Hospital, Dharwad, India, were taken for the study. The immunohistochemical staining procedure was performed using monoclonal anti Bcl-2 antibody, as directed by the manufacturer. Results: Thirty six cases (72%) out of 50 cases showed a positive e…

Pathologymedicine.medical_specialtySalivary glandbusiness.industryCanalicular adenomamedicine.diseaseSalivary Gland Neoplasms:CIENCIAS MÉDICAS [UNESCO]ImmunohistochemistryStainingGene Expression Regulation Neoplasticmedicine.anatomical_structureOtorhinolaryngologyProto-Oncogene Proteins c-bcl-2Oral and maxillofacial pathologyMonoclonalUNESCO::CIENCIAS MÉDICASmedicineImmunohistochemistryHumansSurgerybusinessGeneral DentistrySurvival rateLymph node
researchProduct

Hemophagocytic syndrome in a patient with disseminated tuberculosis: a case report

2018

Hemophagocytic syndrome (HS) is a rare disorder of the immune system. It is characterized by fever, lymphadenopathy, hepatosplenomegaly, cytopenia and hyperferritinemia. The cause differs in each country suggesting a specific genetic background and epidemiology of infections, and it can be associated with malignant diseases. A rare cause of HS is tuberculosis (TB), we describe a case of HS associated with disseminated Mycobacterium tuberculosis (MT) infection in a patient from Sudan. He presented diarrhea, fever, pancytopenia, thickened and dilated bowel loops and lymph nodes enlargement at ultrasound and computed tomography scan. A bone marrow biopsy performed to rule out a lymphoma reveal…

Pathologymedicine.medical_specialtySettore MED/09 - Medicina InternaTuberculosisHepatosplenomegalyMycobacterium tuberculosis.lcsh:MedicineMycobacterium tuberculosiMycobacterium tuberculosisBiopsymedicineHemophagocytic lymphohistiocytosis disseminated tuberculosis; Hemophagocytic syndrome; Mycobacterium tuberculosis; Medicine (all)hemophagocytic lymphohistiocytosis disseminated tuberculosisCytopeniabiologymedicine.diagnostic_testbusiness.industryMedicine (all)lcsh:RGeneral Medicinebiology.organism_classificationmedicine.diseasePancytopeniaLymphomaBronchoalveolar lavageHemophagocytic lymphohistiocytosis disseminated tuberculosimedicine.symptombusinessHemophagocytic syndromeItalian Journal of Medicine
researchProduct

Study of the immunophenotype of the inflammatory cells in melanomas with regression and halo nevi.

2015

Abstract The pathogenesis and prognostic implications of regression in melanoma are not well understood. It has traditionally been considered an immunologically mediated phenomenon. Improvement in the knowledge of the mechanisms that lead to regression may prove to be of great value in an era in which treatments oriented to the augmentation of the host's immunity against melanoma have demonstrated excellent clinical results. This study was designed to improve the understanding of the mechanisms underlying melanoma regression and the differences between similar situations in benign melanocytic nevus. The study sample consisted of 77 lesions: 62 melanomas and 15 halo nevi. The following marke…

Pathologymedicine.medical_specialtySkin NeoplasmsDermatologyT-Lymphocytes RegulatoryPathology and Forensic MedicineImmunophenotypingImmunophenotypingLymphocytes Tumor-InfiltratingPredictive Value of TestsBiomarkers TumorMedicineCytotoxic T cellHumansBenign melanocytic nevusneoplasmsMelanomaInflammationbiologybusiness.industryMelanomaFOXP3General Medicinemedicine.diseaseFibrosisImmunohistochemistryPhenotypeGranzymeNeoplasm Regression Spontaneousbiology.proteinInterleukin-3 receptorbusinessCD8Nevus HaloT-Lymphocytes CytotoxicThe American Journal of dermatopathology
researchProduct

Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts.

2010

Background Although multimodality treatment can induce high rate of remission in many subtypes of non-Hodgkin's lymphoma (NHL), significant proportions of patients relapse with incurable disease. The effect of human bone marrow (BM) mesenchymal stem cells (MSC) on tumor cell growth is controversial, and no specific information is available on the effect of BM-MSC on NHL. Methodology/Principal Findings The effect of BM-MSC was analyzed in two in vivo models of disseminated non-Hodgkin's lymphomas with an indolent (EBV− Burkitt-type BJAB, median survival = 46 days) and an aggressive (EBV+ B lymphoblastoid SKW6.4, median survival = 27 days) behavior in nude-SCID mice. Intra-peritoneal (i.p.) i…

Pathologymedicine.medical_specialtyStromal cellTransplantation HeterologousMice Nudelcsh:Medicinemesenchimal stem cellsMice SCIDMiceimmune system diseaseshemic and lymphatic diseasesmesenchymal stem cells non-Hodgkin's lymphoma.AnimalsHumansMedicinehuman lymphoma xenograft; mesenchimal stem cellsOncology/Hematological Malignancieslcsh:ScienceSCID MiceMultidisciplinaryHematology/Bone Marrow and Stem Cell Transplantationbusiness.industryLymphoma Non-HodgkinLymphoblastlcsh:RMesenchymal stem cellNon-Hodgkin's LymphomaMesenchymal Stem CellsHematopoietic Stem Cellsmedicine.diseaseCoculture TechniquesLymphomaNon-Hodgkin's lymphomaEndothelial stem cellTransplantationApoptosislcsh:QHematology/Lymphomas and Chronic Lymphoblastic LeukemiabusinessMesenchymal Stem Cells; SCID Mice; Non-Hodgkin's LymphomaResearch Articlehuman lymphoma xenograft
researchProduct

Neurofilament is an autoantigenic determinant in myasthenia gravis

1999

Intratumorous expression of a 153-kd protein (p153), which contains an acetylcholine receptor-like epitope, is the only tumor marker described to date that significantly associates with thymoma in paraneoplastic myasthenia gravis (MG). Here, we report that p153 is identical to the midsize neurofilament, as verified by immunohistochemistry, immunofluorescence, and western blot analysis. Furthermore, the acetylcholine receptor-like epitope of the midsize neurofilament (NF-M) was identified by peptide epitope mapping. We also show, using T-cell proliferation assays, a significantly increased response of intratumorous T cells to a recombinant midsize neurofilament fragment in thymoma patients w…

Pathologymedicine.medical_specialtyThymomamusic.instrumentNeurofilamentmedicine.diagnostic_testBiologymedicine.diseaseImmunofluorescenceFollicular hyperplasiaMyasthenia gravisEpitopeNeurologyhemic and lymphatic diseasesmedicineImmunohistochemistryNeurology (clinical)musicAcetylcholine receptorAnnals of Neurology
researchProduct